Matsuyama Shigefumi, Imazuru Tomohiro, Uchiyama Masateru, Ota Hiroo, Iida Mitsuru, Shimokawa Tomoki
Department of Cardiovascular Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan; Department of Cardiovascular Surgery, Teikyo University Hospital, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8606, Japan.
Department of Cardiovascular Surgery, Teikyo University Hospital, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8606, Japan.
Int J Surg Case Rep. 2020;73:253-256. doi: 10.1016/j.ijscr.2020.07.054. Epub 2020 Jul 17.
Primary malignant pericardial mesothelioma is a rare tumor that is very difficult to diagnose. Furthermore, it is a lethal disease, because patients usually have progressed at the time of referral.
We report a 44-year-old man with primary malignant pericardial mesothelioma. He was referred to our hospital for the diagnosis and treatment of a massive pericardial effusion and huge tumor. Pericardiocentesis was performed, but we could not obtain definitive diagnosis, and the cardiac tamponade continued along with the signs/symptoms. He required surgical intervention for the diagnosis and treatment. After surgery, his signs/symptoms improved. He received adjuvant therapy, although he died 7 months after surgery.
Primary malignant pericardial mesothelioma is a rare tumor. The most common signs and symptoms are related to constriction of the heart by the tumor and/or effusion. Even if the pericardial fluid specimen obtained by pericardiocentesis is negative for malignant cells, primary malignant pericardial mesothelioma should be included in the differential diagnosis. Because the malignancy is usually advanced at the time of diagnosis, it has been difficult to cure. Radiation and chemotherapy have been used in addition to surgery, but have been minimally effective.
The outcome of our patient with pericardial malignant mesothelioma was dismal. The indications for surgical intervention should be carefully considered except for critical cases requiring alleviation of immediate life-threating conditions.
原发性恶性心包间皮瘤是一种罕见肿瘤,极难诊断。此外,它是一种致命疾病,因为患者在转诊时病情通常已进展。
我们报告一名44岁原发性恶性心包间皮瘤男性患者。他因大量心包积液和巨大肿瘤被转诊至我院进行诊断和治疗。进行了心包穿刺术,但我们未能获得明确诊断,心脏压塞伴随体征/症状持续存在。他需要手术干预以进行诊断和治疗。术后,他的体征/症状有所改善。他接受了辅助治疗,尽管术后7个月死亡。
原发性恶性心包间皮瘤是一种罕见肿瘤。最常见的体征和症状与肿瘤和/或积液导致的心脏受压有关。即使通过心包穿刺术获得的心包液标本恶性细胞检测为阴性,原发性恶性心包间皮瘤也应列入鉴别诊断。由于恶性肿瘤在诊断时通常已进展,难以治愈。除手术外还使用了放疗和化疗,但效果甚微。
我们这位心包恶性间皮瘤患者的预后很差。除了需要缓解即刻危及生命状况的危急情况外,应仔细考虑手术干预的指征。